2025 Webinar Series: From Tissue Banking to Advanced Therapies: Regulatory Pathways and Strategic Transitions in Tissue Engineering (Group)

Includes a Live Web Event on 09/03/2025 at 2:00 PM (EDT)

Description: Join us on September 3 for “From Tissue Banking to Advanced Therapies: Regulatory Pathways and Strategic Transitions in Tissue Engineering,” a webinar exploring how tissue banks can strategically expand into the field of Advanced Therapy Medicinal Products (ATMPs). Learn how your existing strengths, like donor screening, sterility, and tissue access, can support a transition into tissue engineering and GMP-compliant manufacturing. This session offers practical insights into the regulatory landscape and steps to move toward clinical innovation. Perfect for professionals focused on advancement, strategy, and the future of tissue-based therapies.

Target Audience: This session is ideal for professionals in tissue banking who are involved in or interested in innovation, regulatory strategy, and clinical advancement.

Juan Pablo Aguilar Alemán, PhD

National Academic Director of Biomedical Engineering

Tecnológico de Monterrey

Juan Pablo holds a PhD in Biomedicine and Tissue Engineering and an MSc inBiomedical Engineering from the University of Barcelona, along with a BSc inBiomedical Engineering from Tecnológico de Monterrey. He is a Level I member ofMexico’s National System of Researchers (SNI-I) and a current member of the Scientificand Technical Affairs Committee (STAC) of the AmericanAssociation of Tissue Banks (AATB).

He brings over 15 years of international experience in translationalresearch, biomedical innovation, and regulatory science. He has led thedevelopment and scale-up of collagen-based medical devices, includingdecellularized tissues, heart valves, dermis, and peripheral nerves, securingregulatory approvals and national patents. His expertise spans the full productlifecycle under GMP and ISO 13485 standards, with a strong focus onquality-by-design and risk-based methodologies.

Currently, he leads the scientific pipeline at ITC(Instituto de Terapia Celular), driving the development of AdvancedTherapy Medicinal Products (ATMPs) based on mesenchymal stromalcells (MSCs), extracellular vesicles (EVs), and biofunctional scaffolds. Inparallel, he serves as National Academic Director of BiomedicalEngineering at Tecnológico de Monterrey, fosteringinnovation-driven education and strategic collaboration between academia,industry, and clinical stakeholders.